Brendan Limone

1.3k total citations
36 papers, 996 citations indexed

About

Brendan Limone is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brendan Limone has authored 36 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 10 papers in Economics and Econometrics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brendan Limone's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Cystic Fibrosis Research Advances (6 papers). Brendan Limone is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Cystic Fibrosis Research Advances (6 papers). Brendan Limone collaborates with scholars based in United States, Netherlands and France. Brendan Limone's co-authors include Craig I Coleman, Soyon Lee, Diana M Sobieraj, Rajbir Kaur, Matthew Roberts, Matthew W. Parker, Charles M. Jones, Gary V. Heller, Aline Iskandar and Hye‐Jin Kim and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Brendan Limone

34 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brendan Limone United States 15 261 199 145 130 127 36 996
G. Craig Wood United States 18 283 1.1× 69 0.3× 61 0.4× 46 0.4× 92 0.7× 44 1.1k
Lee Stern United States 15 78 0.3× 134 0.7× 42 0.3× 71 0.5× 170 1.3× 64 884
Gregory Reardon United States 17 115 0.4× 167 0.8× 28 0.2× 50 0.4× 41 0.3× 42 847
Mohamed Hussein Egypt 14 120 0.5× 15 0.1× 83 0.6× 93 0.7× 67 0.5× 55 968
Nermin Hadziosmanovic Sweden 18 711 2.7× 357 1.8× 16 0.1× 36 0.3× 48 0.4× 44 1.5k
Alberta L. Warner United States 15 793 3.0× 49 0.2× 29 0.2× 31 0.2× 38 0.3× 38 1.3k
Kellee Kaulback United States 7 62 0.2× 30 0.2× 87 0.6× 36 0.3× 29 0.2× 11 952
Rajkumar Doshi United States 23 786 3.0× 134 0.7× 12 0.1× 52 0.4× 336 2.6× 179 1.8k
Soyon Lee United States 12 324 1.2× 6 0.0× 147 1.0× 169 1.3× 54 0.4× 34 900
Jennifer A. Rymer United States 22 1.0k 4.0× 252 1.3× 30 0.2× 79 0.6× 305 2.4× 100 1.7k

Countries citing papers authored by Brendan Limone

Since Specialization
Citations

This map shows the geographic impact of Brendan Limone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brendan Limone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brendan Limone more than expected).

Fields of papers citing papers by Brendan Limone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brendan Limone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brendan Limone. The network helps show where Brendan Limone may publish in the future.

Co-authorship network of co-authors of Brendan Limone

This figure shows the co-authorship network connecting the top 25 collaborators of Brendan Limone. A scholar is included among the top collaborators of Brendan Limone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brendan Limone. Brendan Limone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Princic, Nicole, et al.. (2024). Real-world treatment patterns, healthcare resource utilisation and costs in patients with SLE in the USA. Lupus Science & Medicine. 11(2). e001290–e001290.
2.
Khandker, Rezaul Karim, et al.. (2023). Prevalence and impact of antipsychotic discontinuation among commercially-insured patients with bipolar disorder. Journal of Medical Economics. 26(1). 878–885. 2 indexed citations
3.
4.
Thorat, Teja, Lisa J. McGarry, Machaon Bonafede, et al.. (2021). Healthcare resource utilization and costs among children with cystic fibrosis in the United States. Pediatric Pulmonology. 56(9). 2833–2844. 14 indexed citations
5.
Thorat, Teja, Lisa J. McGarry, Brendan Limone, et al.. (2021). Long-Term Impact of Ivacaftor on Healthcare Resource Utilization Among People with Cystic Fibrosis in the United States. Pulmonary Therapy. 7(1). 281–293. 6 indexed citations
6.
Accortt, Neil A., James Chung, Machaon Bonafede, Brendan Limone, & David M. Mannino. (2017). Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations. International Journal of COPD. Volume 12. 2085–2094. 7 indexed citations
7.
Mearns, Elizabeth S., et al.. (2017). Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US. ClinicoEconomics and Outcomes Research. Volume 9. 485–494. 5 indexed citations
8.
9.
10.
Kohn, Christine G., Matthew W. Parker, Brendan Limone, & Craig I Coleman. (2014). Cost-Effectiveness of Ranolazine Added to Standard-of-Care Treatment in Patients With Chronic Stable Angina Pectoris. The American Journal of Cardiology. 113(8). 1306–1311. 12 indexed citations
11.
Limone, Brendan, William L. Baker, Elizabeth S. Mearns, et al.. (2014). Common flaws exist in published cost-effectiveness models of pharmacologic stroke prevention in atrial fibrillation. Journal of Clinical Epidemiology. 67(10). 1093–1102. 7 indexed citations
12.
Coleman, Craig I & Brendan Limone. (2013). Cost-effectiveness of universal versus assay-driven antiplatelet therapy in acute coronary syndrome patients. Value in Health. 16(3). A284–A284.
13.
Coleman, Craig I & Brendan Limone. (2013). Cost-Effectiveness of Universal and Platelet Reactivity Assay-Driven Antiplatelet Therapy in Acute Coronary Syndrome. The American Journal of Cardiology. 112(3). 355–362. 21 indexed citations
14.
Coleman, Craig I, Brendan Limone, & Soyon Lee. (2013). COST-EFFECTIVENESS OF UNIVERSAL OR PHENOTYPE-DRIVEN SELECTION OF DUAL ANTIPLATELET TREATMENT IN ACUTE CORONARY SYNDROME. Journal of the American College of Cardiology. 61(10). E6–E6. 1 indexed citations
15.
Limone, Brendan, et al.. (2013). Timing of recurrent venous thromboembolism early after the index event: A meta-analysis of randomized controlled trials. Thrombosis Research. 132(4). 420–426. 41 indexed citations
16.
Limone, Brendan, William L. Baker, Jeffrey Kluger, & Craig I Coleman. (2013). Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Cost-Effectiveness Models. PLoS ONE. 8(4). e62183–e62183. 48 indexed citations
17.
18.
Limone, Brendan & Craig I Coleman. (2013). Universal versus platelet reactivity assay-driven use of P2Y12 inhibitors in acute coronary syndrome patients. Thrombosis and Haemostasis. 111(1). 103–110. 7 indexed citations
19.
Iskandar, Aline, Brendan Limone, Matthew W. Parker, et al.. (2012). Gender differences in the diagnostic accuracy of SPECT myocardial perfusion imaging: A bivariate meta-analysis. Journal of Nuclear Cardiology. 20(1). 53–63. 32 indexed citations
20.
Collins, Courtney, et al.. (2010). Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Research and Clinical Practice. 92(2). 145–152. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Craig Wood Breakdown of academic impact, for papers by Lee Stern Breakdown of academic impact, for papers by Gregory Reardon Breakdown of academic impact, for papers by Mohamed Hussein Breakdown of academic impact, for papers by Nermin Hadziosmanovic Breakdown of academic impact, for papers by Alberta L. Warner Breakdown of academic impact, for papers by Kellee Kaulback Breakdown of academic impact, for papers by Rajkumar Doshi Breakdown of academic impact, for papers by Soyon Lee Breakdown of academic impact, for papers by Jennifer A. Rymer
Rankless by CCL
2026